Skip to main content
Breast CancerCancerWomen's healthProcedure

What this study is

This trial is to investigate if in patients with clinically node positive breast cancer undergoing upfront surgery, treatment with TAS and ART is superior to ALND in terms of arm-related Quality of Life (QoL) and occurrence of lymphedema two years after randomization.

What's being tested

  • Axillary lymph node dissection (ALND)

    Intervention · PROCEDURE

    Surgical removal of lymphatic tissue within the anatomical boundaries of the axilla (standard of care in the upfront surgery setting in patients with cN+ BC)

  • Axillary radiotherapy (ART)

    Intervention · PROCEDURE

    Axillary irradiation

Study details

Official title
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery: An International, Randomized Superiority Trial (OPBC-10/ NOAX)
Sponsor
University Hospital, Basel, Switzerland
Conditions
Breast Cancer
Enrolling
1,060 people
Starts
2026-01-01
Est. completion
2037-12
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗